Ambiotis Overview

  • Founded
  • 2007
Founded
  • Status
  • Private
  • Employees
  • 13
Employees
  • Latest Deal Type
  • Crowdfunding
  • Latest Deal Amount
  • $110K
Latest Deal Amount
  • Investors
  • 1

Ambiotis General Information

Description

Operator of a contract research organization. The company offers a functional approach to the inflammatory process and the immunostimulation with a set of in vivo and in vitro tests.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Commercial Services
Other Industries
Biotechnology
Primary Office
  • Incubateur Midi-Pyrénées
  • 29 Rue Jeanne Marvig
  • 31400 Toulouse
  • France
+33 05 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ambiotis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Equity Crowdfunding $110K 00000 Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Ambiotis’s complete valuation and funding history, request access »

Ambiotis Executive Team (1)

Name Title Board Seat Contact Info
Marc Dubourdeau Ph.D Propriétaire, Chief Executive Officer & Président - Directeur scientifique
To view Ambiotis’s complete executive team members history, request access »

Ambiotis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ambiotis Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Nubbo Accelerator/Incubator 000 0000 000000 0
To view Ambiotis’s complete investors history, request access »